These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7780090)

  • 41. Tuberculosis due to Mycobacterium kansasii.
    Elder JL; Edwards FG; Abrahams EW
    Aust N Z J Med; 1977 Feb; 7(1):8-13. PubMed ID: 266899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
    Small PM; Schecter GF; Goodman PC; Sande MA; Chaisson RE; Hopewell PC
    N Engl J Med; 1991 Jan; 324(5):289-94. PubMed ID: 1898769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short-duration treatment of pulmonary tuberculosis.
    Pilheu JA
    Chest; 1977 May; 71(5):583-6. PubMed ID: 852337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A; Burman W; Benator D; Khan A; Bozeman L
    Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.
    Kennedy N; Berger L; Curram J; Fox R; Gutmann J; Kisyombe GM; Ngowi FI; Ramsay AR; Saruni AO; Sam N; Tillotson G; Uiso LO; Yates M; Gillespie SH
    Clin Infect Dis; 1996 May; 22(5):827-33. PubMed ID: 8722940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S; Futsuki Y; Tomari S; Araki J
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term results of medical treatment in Mycobacterium intracellulare infection.
    Dutt AK; Stead WW
    Am J Med; 1979 Sep; 67(3):449-53. PubMed ID: 474589
    [No Abstract]   [Full Text] [Related]  

  • 51. Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
    Gonzalez Montaner LJ; Leston JM; Cetrangolo A; Szemzo J; Calvete C; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1976; 51(1):87-9. PubMed ID: 1030316
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: second report.
    Tubercle; 1976 Jun; 57(2):105-13. PubMed ID: 822547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
    Cosson MA; Bertrand JB; Martin C; Veziris N; Picard C; Goulvestre C; Coignard S; Benoit JP; Silvera S; Moro MR; Poyart C; Morand PC
    J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ; Perng RP
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin.
    Pezzia W; Raleigh JW; Bailey MC; Toth EA; Silverblatt J
    Rev Infect Dis; 1981; 3(5):1035-9. PubMed ID: 7339801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A resected case of Mycobacterium szulgai pulmonary disease.
    Tsuyuguchi K; Amitani R; Matsumoto H; Tanaka E; Suzuki K; Yanagihara K; Mizuno H; Hitomi S; Kuze F
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):258-60. PubMed ID: 9526201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Short-term initial chemotherapy with isoniazid, rifampin and ethambutol (streptomycin) in biphasic (3+6) administration, from the intermittent (2/7) beginning. Results after 2 years (cooperative experiment)].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(2):79-90. PubMed ID: 195328
    [No Abstract]   [Full Text] [Related]  

  • 59. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
    Koh WJ; Kwon OJ; Park YK; Lew WJ; Bai GH
    Eur Respir J; 2005 Sep; 26(3):557. PubMed ID: 16135740
    [No Abstract]   [Full Text] [Related]  

  • 60. A controlled trial of individually-adapted short-course chemotherapy versus two-year scheme in original treatment of pulmonary tuberculosis. Report after a five-year follow-up.
    Favez G; Leuenberger P
    Chest; 1982 Oct; 82(4):426-9. PubMed ID: 6811217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.